Use of any nonequimolar PSA immunoassay that contains a seminal plasma derived PSA calibrant could result in skewed PSA serum level reporting leading to either overdiagnosis or underdiagnosis of PCa. The gene discussed is KLK3; the disease is posterior cortical atrophy.